fludarabine and sesquiterpenes

fludarabine has been researched along with sesquiterpenes in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brennan, P; Burnett, AK; Fegan, C; Hewamana, S; Jenkins, C; Jordan, CT; Lin, TT; Pepper, C; Rowntree, C	1

Other Studies

1 other study(ies) available for fludarabine and sesquiterpenes

Article	Year
The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-15, Volume: 14, Issue:24 Topics: Antineoplastic Agents; CD40 Ligand; Cytoprotection; DNA; Drug Synergism; Humans; Interleukin-4; Leukemia, Lymphocytic, Chronic, B-Cell; NF-kappa B; Prognosis; Sesquiterpenes; Vidarabine	2008

Article

Year

The novel nuclear factor-kappaB inhibitor LC-1 is equipotent in poor prognostic subsets of chronic lymphocytic leukemia and shows strong synergy with fludarabine.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Dec-15, Volume: 14, Issue:24

Topics: Antineoplastic Agents; CD40 Ligand; Cytoprotection; DNA; Drug Synergism; Humans; Interleukin-4; Leukemia, Lymphocytic, Chronic, B-Cell; NF-kappa B; Prognosis; Sesquiterpenes; Vidarabine

2008